Loading...
RAY B logo

RaySearch Laboratories AB (publ)OM:RAY B Stock Report

Market Cap SEK 8.3b
Share Price
SEK 241.00
My Fair Value
SEK 365
34.0% undervalued intrinsic discount
1Y46.6%
7D0.8%
Portfolio Value
View

RaySearch Laboratories AB (publ)

OM:RAY B Stock Report

Market Cap: SEK 8.3b

RaySearch Laboratories (RAY B) Stock Overview

A medical technology company, provides software solutions for cancer treatment worldwide. More details

RAY B fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance5/6
Financial Health6/6
Dividends2/6

Rewards

Risk Analysis

No risks detected for RAY B from our risk checks.

RAY B Community Fair Values

Create Narrative

See what 14 others think this stock is worth. Follow their fair value or set your own to get alerts.

RaySearch Laboratories AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for RaySearch Laboratories
Historical stock prices
Current Share PriceSEK 241.00
52 Week HighSEK 373.50
52 Week LowSEK 149.00
Beta1.05
1 Month Change-19.53%
3 Month Change-24.09%
1 Year Change46.59%
3 Year Change403.13%
5 Year Change153.68%
Change since IPO42,429.91%

Recent News & Updates

RaySearch Laboratories AB (publ) (STO:RAY B) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

Aug 19
RaySearch Laboratories AB (publ) (STO:RAY B) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

At kr344, Is It Time To Put RaySearch Laboratories AB (publ) (STO:RAY B) On Your Watch List?

Jul 07
At kr344, Is It Time To Put RaySearch Laboratories AB (publ) (STO:RAY B) On Your Watch List?

Recent updates

RaySearch Laboratories AB (publ) (STO:RAY B) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

Aug 19
RaySearch Laboratories AB (publ) (STO:RAY B) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

At kr344, Is It Time To Put RaySearch Laboratories AB (publ) (STO:RAY B) On Your Watch List?

Jul 07
At kr344, Is It Time To Put RaySearch Laboratories AB (publ) (STO:RAY B) On Your Watch List?

RaySearch Laboratories (STO:RAY B) Is Paying Out A Larger Dividend Than Last Year

May 23
RaySearch Laboratories (STO:RAY B) Is Paying Out A Larger Dividend Than Last Year
User avatar

RayStation And RayCare Upgrades Will Streamline Adaptive Treatment Planning

Integration of AI and new treatment modules is anticipated to boost efficiency, driving demand and potential revenue growth for RaySearch.

RaySearch Laboratories AB (publ)'s (STO:RAY B) 43% Price Boost Is Out Of Tune With Earnings

May 13
RaySearch Laboratories AB (publ)'s (STO:RAY B) 43% Price Boost Is Out Of Tune With Earnings

RaySearch Laboratories (STO:RAY B) Is Paying Out A Larger Dividend Than Last Year

May 09
RaySearch Laboratories (STO:RAY B) Is Paying Out A Larger Dividend Than Last Year

RaySearch Laboratories (STO:RAY B) Is Increasing Its Dividend To SEK3.00

Apr 25
RaySearch Laboratories (STO:RAY B) Is Increasing Its Dividend To SEK3.00

RaySearch Laboratories (STO:RAY B) Is Increasing Its Dividend To SEK3.00

Apr 09
RaySearch Laboratories (STO:RAY B) Is Increasing Its Dividend To SEK3.00

RaySearch Laboratories' (STO:RAY B) Earnings May Just Be The Starting Point

Mar 01
RaySearch Laboratories' (STO:RAY B) Earnings May Just Be The Starting Point

RaySearch Laboratories' (STO:RAY B) Dividend Will Be Increased To SEK3.00

Feb 26
RaySearch Laboratories' (STO:RAY B) Dividend Will Be Increased To SEK3.00

RaySearch Laboratories AB (publ)'s (STO:RAY B) Shares Climb 28% But Its Business Is Yet to Catch Up

Nov 09
RaySearch Laboratories AB (publ)'s (STO:RAY B) Shares Climb 28% But Its Business Is Yet to Catch Up

RaySearch Laboratories AB (publ) (STO:RAY B) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable

May 21
RaySearch Laboratories AB (publ) (STO:RAY B) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable

The Returns At RaySearch Laboratories (STO:RAY B) Aren't Growing

May 11
The Returns At RaySearch Laboratories (STO:RAY B) Aren't Growing

RaySearch Laboratories (STO:RAY B) Will Want To Turn Around Its Return Trends

Oct 04
RaySearch Laboratories (STO:RAY B) Will Want To Turn Around Its Return Trends

Does RaySearch Laboratories (STO:RAY B) Have A Healthy Balance Sheet?

Jul 10
Does RaySearch Laboratories (STO:RAY B) Have A Healthy Balance Sheet?

Is RaySearch Laboratories (STO:RAY B) Using Too Much Debt?

Nov 17
Is RaySearch Laboratories (STO:RAY B) Using Too Much Debt?

Shareholder Returns

RAY BSE Healthcare ServicesSE Market
7D0.8%0.4%2.1%
1Y46.6%26.1%0.2%

Return vs Industry: RAY B exceeded the Swedish Healthcare Services industry which returned 26.1% over the past year.

Return vs Market: RAY B exceeded the Swedish Market which returned 0.2% over the past year.

Price Volatility

Is RAY B's price volatile compared to industry and market?
RAY B volatility
RAY B Average Weekly Movement4.2%
Healthcare Services Industry Average Movement7.7%
Market Average Movement5.8%
10% most volatile stocks in SE Market12.1%
10% least volatile stocks in SE Market3.0%

Stable Share Price: RAY B has not had significant price volatility in the past 3 months compared to the Swedish market.

Volatility Over Time: RAY B's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000431Johan Lofwww.raysearchlabs.com

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; and machine learning and liver ablation solutions.

RaySearch Laboratories AB (publ) Fundamentals Summary

How do RaySearch Laboratories's earnings and revenue compare to its market cap?
RAY B fundamental statistics
Market capSEK 8.26b
Earnings (TTM)SEK 192.95m
Revenue (TTM)SEK 1.25b
42.8x
P/E Ratio
6.6x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RAY B income statement (TTM)
RevenueSEK 1.25b
Cost of RevenueSEK 107.02m
Gross ProfitSEK 1.15b
Other ExpensesSEK 952.56m
EarningsSEK 192.95m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Nov 07, 2025

Earnings per share (EPS)5.63
Gross Margin91.46%
Net Profit Margin15.41%
Debt/Equity Ratio0%

How did RAY B perform over the long term?

See historical performance and comparison

Dividends

1.2%
Current Dividend Yield
53%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/09/10 18:50
End of Day Share Price 2025/09/10 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

RaySearch Laboratories AB (publ) is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Kristofer Liljeberg-SvenssonDNB Carnegie
Hans MählerHandelsbanken Capital Markets